Persistence of Blood Pressure Reduction Following Renal Denervation Across Short, Medium, and Long Term Follow-Up
Abstract Body: Introduction Resistant and uncontrolled hypertension pose persistent clinical and public health challenges. Renal denervation, a catheter-based procedure targeting renal sympathetic nerves, has emerged as a promising approach to lower blood pressure by reducing sympathetic overactivity. Hypothesis A systematic review and meta-analysis of sham-controlled trials investigated whether renal denervation results in sustained blood pressure reduction across short-, medium-, and long-term follow-up. Methods We searched PubMed, Embase, CENTRAL, and Web of Science through March 2025. The protocol was registered in PROSPERO (CRD420251015937). Randomized, sham-controlled trials of renal denervation in resistant/uncontrolled hypertension were included. Primary outcomes were ambulatory blood pressure (daytime, nighttime, and 24-hour); secondary outcomes included office and home blood pressure measurements. Follow-up durations were categorized into three groups: less than 6 months, 6–12 months, and greater than 12 months. Risk of bias was assessed using RoB-2. Results Twenty trials (25 reports) with 2,167 RDN patients and 1,744 sham controls were included. Most trials had a low risk of bias. RDN significantly reduced 24-hour SBP (–3.29 mmHg, 95% CI: –5.91 to –0.67) and DBP (–1.42 mmHg, 95% CI: –2.29 to –0.55), despite high heterogeneity (I2 > 90%). Daytime DBP showed a significant reduction (–2.90 mmHg, 95% CI: –4.39 to –1.41), while other BP measures were less consistent. Home SBP was significantly reduced (–5.04 mmHg, 95% CI: –8.50 to –1.58). At 6–12 months, 24-hour SBP reduction persisted (–3.36 mmHg, 95% CI: –5.71 to –1.01), but DBP effects were nonsignificant. Long-term follow-up revealed nonsignificant changes in systolic blood pressure and diastolic blood pressure. Conclusions Renal denervation modestly lowers BP in the short term (<6 months). Mid-term SBP reduction persists, but diastolic and long-term effects are inconsistent. These findings highlight the need for refined patient selection, optimized techniques, and longer follow-up trials.
Ebrahimi, Pouya
(
University Hospitals Birmingham
, Birmingham , West Midland , United Kingdom )
Namazi, Mohammad Javad
(
Mayo Clinic
, Rochester , Minnesota , United States )
Rezasoltani, Mahsa
(
Mayo Clinic
, Rochester , Minnesota , United States )
Moradi, Ali
(
Blake hospital
, Bradenton , Florida , United States )
Montazeri Namin, Sara
(
Rajaei Cardiology Hospital
, Tehran , Tehran , Iran (the Islamic Republic of) )
Eshraghi, Reza
(
Isfahan University of Medical Scien
, Isfahan , Iran (the Islamic Republic of) )
Bahrami, Ashkan
(
Kashan University of Medical Sciences
, Kashan , Kashan , Iran (the Islamic Republic of) )
Noroozi, Matin
(
Isfahan University of Medical Sciences
, Isfahan , Isfahan , Iran (the Islamic Republic of) )
Akbari, Touba
(
Shahid Beheshti University of Medical Sciences
, Tehran , Tehran , Iran (the Islamic Republic of) )
Behbudi, Fatemeh
(
Bushehr University of Medical Sciences
, Bushehr , Bushehr , Iran (the Islamic Republic of) )
Mandegar, Mohammad Hossein
(
Tehran University of Medical Sciences
, Tehran , Tehran , Iran (the Islamic Republic of) )
Yazdani, Mohammad Sepehr
(
Kashan University of Medical Sciences
, Kashan , Kashan , Iran (the Islamic Republic of) )
Pirdehghan, Reza
(
Shahid Beheshti University of Medical Sciences
, Tehran , Tehran , Iran (the Islamic Republic of) )
Ahmed, Raheel
(
Royal Brompton Hospital
, Newcastle upon Tyne , United Kingdom )
Shahid, Farhan
(
Queen Elizabeth Hospital, NHS
, Birmingham , United Kingdom )
Author Disclosures:
Pouya Ebrahimi:DO NOT have relevant financial relationships
| Fatemeh Behbudi:No Answer
| Mohammad Hossein Mandegar:No Answer
| Mohammad Sepehr Yazdani:No Answer
| Reza Pirdehghan:No Answer
| Raheel Ahmed:No Answer
| Farhan Shahid:No Answer
| Mohammad Javad Namazi:DO NOT have relevant financial relationships
| Mahsa Rezasoltani:DO NOT have relevant financial relationships
| Ali Moradi:DO NOT have relevant financial relationships
| Sara Montazeri Namin:No Answer
| Reza Eshraghi:DO NOT have relevant financial relationships
| Ashkan Bahrami:No Answer
| matin noroozi:No Answer
| Touba Akbari:No Answer
